KemPharm Post Positive Results From Phase 1 Trial

News   Jan 11, 2017 | Original Story From KemPharm

 
KemPharm Post Positive Results From Phase 1 Trial
 
 
 
 

RELATED ARTICLES

ACD/Labs Collaboration Provides NMR Data to Brazilian Biodiversity Natural Products Database

News

ACD/Labs announces collaboration with researchers at Brazilian Biodiversity database in support of chemical and pharmaceutical R&D.

READ MORE

A Promising Framework for Predicting Drug Resistance in Cancer

News

The system works by predicting the co-occurrence of about 500 known tumour alterations, as well as their response to over 200 common cancer drugs.

READ MORE

Artificial Blood Vessels Mimic Rare Accelerated Aging Disease

News

Lab-grown blood vessels provide platform for studying premature aging syndrome and other rare diseases.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE